132 related articles for article (PubMed ID: 2024473)
1. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups.
Fotiadis C; Kilpatrick DR; Lipton HL
Virology; 1991 May; 182(1):365-70. PubMed ID: 2024473
[TBL] [Abstract][Full Text] [Related]
2. Predominant binding of Theiler's viruses to a 34-kilodalton receptor protein on susceptible cell lines.
Kilpatrick DR; Lipton HL
J Virol; 1991 Oct; 65(10):5244-9. PubMed ID: 1895381
[TBL] [Abstract][Full Text] [Related]
3. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains.
Pevear DC; Borkowski J; Calenoff M; Oh CK; Ostrowski B; Lipton HL
Virology; 1988 Jul; 165(1):1-12. PubMed ID: 2838951
[TBL] [Abstract][Full Text] [Related]
4. Role of sialyloligosaccharide binding in Theiler's virus persistence.
Zhou L; Lin X; Green TJ; Lipton HL; Luo M
J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
[TBL] [Abstract][Full Text] [Related]
5. Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence.
Zhang L; Senkowski A; Shim B; Roos RP
J Virol; 1993 Jul; 67(7):4404-8. PubMed ID: 8510228
[TBL] [Abstract][Full Text] [Related]
6. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells.
Hertzler S; Kallio P; Lipton HL
Virology; 2001 Aug; 286(2):336-44. PubMed ID: 11485401
[TBL] [Abstract][Full Text] [Related]
7. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment.
Shah AH; Lipton HL
Virology; 2002 Dec; 304(2):443-50. PubMed ID: 12504583
[TBL] [Abstract][Full Text] [Related]
8. Theiler's virus-specified polypeptides made in BHK-21 cells.
Lipton HL; Rozhon EJ; Black D
J Gen Virol; 1984 Jun; 65 ( Pt 6)():1095-100. PubMed ID: 6327893
[TBL] [Abstract][Full Text] [Related]
9. The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence.
Lipton HL; Calenoff M; Bandyopadhyay P; Miller SD; Dal Canto MC; Gerety S; Jensen K
J Virol; 1991 Aug; 65(8):4370-7. PubMed ID: 2072455
[TBL] [Abstract][Full Text] [Related]
10. Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence.
Pritchard AE; Jensen K; Lipton HL
J Virol; 1993 Jul; 67(7):3901-7. PubMed ID: 8510210
[TBL] [Abstract][Full Text] [Related]
11. A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence.
Pritchard AE; Calenoff MA; Simpson S; Jensen K; Lipton HL
J Virol; 1992 Apr; 66(4):1951-8. PubMed ID: 1548749
[TBL] [Abstract][Full Text] [Related]
12. Comparison of structural and nonstructural proteins of virulent and less virulent Theiler's virus isolates using two-dimensional gel electrophoresis.
Rozhon EJ; Kratochvil JD; Lipton HL
Virus Res; 1985 Feb; 2(1):11-28. PubMed ID: 2984856
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses.
Rodriguez M; Roos RP
J Virol; 1992 Jan; 66(1):217-25. PubMed ID: 1727485
[TBL] [Abstract][Full Text] [Related]
14. Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence.
Stein SB; Zhang L; Roos RP
J Virol; 1992 Jul; 66(7):4508-17. PubMed ID: 1602556
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses.
Reddi HV; Lipton HL
J Virol; 2002 Aug; 76(16):8400-7. PubMed ID: 12134043
[TBL] [Abstract][Full Text] [Related]
16. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
Jnaoui K; Minet M; Michiels T
J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system.
Lipton HL; Pritchard AE; Calenoff MA
J Gen Virol; 1998 May; 79 ( Pt 5)():1001-4. PubMed ID: 9603314
[TBL] [Abstract][Full Text] [Related]
18. Neurovirulence determinants of genetically engineered Theiler viruses.
Fu JL; Stein S; Rosenstein L; Bodwell T; Routbort M; Semler BL; Roos RP
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4125-9. PubMed ID: 2161533
[TBL] [Abstract][Full Text] [Related]
19. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
Luo M; Toth KS; Zhou L; Pritchard A; Lipton HL
Virology; 1996 Jun; 220(1):246-50. PubMed ID: 8659122
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
Nitayaphan S; Toth MM; Roos RP
J Virol; 1985 Feb; 53(2):651-7. PubMed ID: 2578578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
